Llwytho...
Breaking Bottlenecks for the TCR Therapy of Cancer
Immune checkpoint inhibitors have redefined the treatment of cancer, but their efficacy depends critically on the presence of sufficient tumor-specific lymphocytes, and cellular immunotherapies develop rapidly to fill this gap. The paucity of suitable extracellular and tumor-associated antigens in s...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Cells |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
MDPI
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7564186/ https://ncbi.nlm.nih.gov/pubmed/32937956 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells9092095 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|